CELL INTELLIGENCE · 肿瘤细胞治疗研究

IL-15 增强间皮素和 CD70 CAR NK 细胞在 PDAC 中的效力，双靶向未带来额外获益

IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.

乳腺癌免疫治疗：从检查点抑制到新兴细胞治疗

Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies.

CAR-T 与 CAR-NK 细胞疗法治疗卵巢癌的当前进展

Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer.

更正：抗间皮素 CAR-NK 细胞作为针对宫颈癌的新型靶向治疗

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

抗间皮素 CAR-NK 细胞作为宫颈癌的新型靶向治疗

Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

重定位抗间皮素 CAR-NK 免疫治疗用于结直肠癌

Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer.

我们的结果提供了临床前证据，表明表达高水平间皮素的结直肠癌亚群可被基于 MSLN-CAR 的免疫治疗有效靶向。